Table 1.
Characteristics of the control and study groups.
| Demographic Data | ||
|---|---|---|
| Variable | AIH [n = 30] |
Control [n = 30] |
| Sex | ||
| Women | 27 (90%) | 25 (83.33%) |
| Men | 3 (10%) | 5 (16.67%) |
| Age [years] Median (range) |
56 (23–80) | 43 (21–69) |
| BMI [kg/m2] Median (range) |
24.91 (18.67–37.11) | 22.60 (17–29.7) |
| Clinical Data | ||
| Disease duration [years] Median (range) |
13 (1–25) | - |
| Treatment Steroids Immunosuppressive agents Steroids + Immunosuppressive agents |
19 (63.33%) 1 (3.33%) 10 (33.34%) |
- - - |
| Family history of AIH Negative Positive |
22 (73.33%) 8 (26.67%) |
- - |
| LC Non-LC |
10 (33.33%) 20 (66.67%) |
- - |
| Smoking status Smoker Non-smoker |
2 (6.67%) 28 (93.33%) |
5 (16.67%) 25 (83.33%) |
| Excessive alcohol consumption Yes No |
0 (0%) 30 (100%) |
2 (6.67%) 28 (93.33%) |
| Allergies Yes No |
6 (20%) 24 (80%) |
- - |
| Comorbidities Yes * No |
15 (50%) 15 (50%) |
- - |
(AIH—autoimmune hepatitis, BMI—body mass index, LC—liver cirrhosis), * including: diabetes, nephrolithiasis, chronic heart failure, arterial hypertension, osteoporosis, bronchial asthma, and glaucoma.